| Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update |
Globe Newswire |
11/12 |
16:05 |
| Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights |
Globe Newswire |
11/12 |
16:05 |
| INNOVATE Corp. Announces Third Quarter 2026 Results |
Globe Newswire |
11/12 |
16:05 |
| PRF Technologies Receives Nasdaq Delisting Determination Regarding Minimum Bid Price Requirement and Requests a Hearing |
Globe Newswire |
11/12 |
16:05 |
| U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027 |
Globe Newswire |
11/12 |
16:05 |
| Merlin, Inc. Reports Third Quarter 2026 Results |
Globe Newswire |
11/12 |
16:05 |
| Shimmick Corporation Announces Third Quarter 2026 Results |
Globe Newswire |
11/12 |
16:05 |
| Birchtech Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| Park Dental Partners Announces Third Quarter 2026 Results |
Globe Newswire |
11/12 |
16:05 |
| LOBO TECHNOLOGIES LTD. Announces Share Consolidation |
Globe Newswire |
11/12 |
16:05 |
| Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
16:05 |
| Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially |
Globe Newswire |
11/12 |
16:05 |
| OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Company |
Globe Newswire |
11/12 |
16:05 |
| Navitas Files Patent Infringement Lawsuit Against Newly Announced Renesas GaN Products |
Globe Newswire |
11/12 |
16:05 |
| Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
16:05 |
| Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentiated ADC Payload Platform |
Globe Newswire |
11/12 |
16:05 |
| Crown Crafts Announces Financial Results for Second Quarter Fiscal 2027 |
Globe Newswire |
11/12 |
16:05 |
| ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026 |
Globe Newswire |
11/12 |
16:05 |
| ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability |
Globe Newswire |
11/12 |
16:05 |
| Jefferson Capital Reports Third Quarter 2026 Results |
Globe Newswire |
11/12 |
16:05 |
| ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing |
Globe Newswire |
11/12 |
16:05 |
| Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates |
Globe Newswire |
11/12 |
16:05 |
| AVAX One Reports Third Quarter 2026 Financial and Operating Results |
Globe Newswire |
11/12 |
16:05 |
| Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| SKYX Reports Record Revenue of $25.7M in Q-3 2026 Compared to $23.9M in Q-3 2025 and 11 Consecutive Quarters of Growth YoY |
Globe Newswire |
11/12 |
16:05 |